Safety of insulin detemir and insulin NPH [neutral protamine Hagedorn] [insulin suspension isophane] in children with type 1 diabetes mellitus.

Trial Profile

Safety of insulin detemir and insulin NPH [neutral protamine Hagedorn] [insulin suspension isophane] in children with type 1 diabetes mellitus.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Insulin detemir; Insulin suspension isophane
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Jul 2009 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
    • 03 Jul 2009 Actual number of patients (83) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top